Search hospitals > Michigan > Ann Arbor

University of Michigan, Kellogg Eye Center

Claim this profile
Ann Arbor, Michigan 48105
Global Leader in Retinitis Pigmentosa
Conducts research for Age-Related Macular Degeneration
Conducts research for Retinal Disease
Conducts research for Eye Diseases
Conducts research for Retinal Dystrophy
77 reported clinical trials
8 medical researchers
Photo of University of Michigan, Kellogg Eye Center in Ann ArborPhoto of University of Michigan, Kellogg Eye Center in Ann ArborPhoto of University of Michigan, Kellogg Eye Center in Ann Arbor

Summary

University of Michigan, Kellogg Eye Center is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Retinitis Pigmentosa, Age-Related Macular Degeneration, Retinal Disease, Eye Diseases, Retinal Dystrophy and other specialties. University of Michigan, Kellogg Eye Center is involved with conducting 77 clinical trials across 97 conditions. There are 8 research doctors associated with this hospital, such as Thiran Jayasundera, MD, Cagri Besirli, Shahzad Mian, MD, and Susan G Elner, MD.

Area of expertise

1Retinitis Pigmentosa
Global Leader
University of Michigan, Kellogg Eye Center has run 22 trials for Retinitis Pigmentosa. Some of their research focus areas include:
PRPF31 positive
USH2A exon 13 mutations positive
USH2A positive
2Age-Related Macular Degeneration
University of Michigan, Kellogg Eye Center has run 10 trials for Age-Related Macular Degeneration.

Top PIs

Clinical Trials running at University of Michigan, Kellogg Eye Center

Retinitis Pigmentosa
Retinal Disease
Retinal Dystrophy
Stargardt Disease
Retinal Degeneration
Age-Related Macular Degeneration
Eye Diseases
Glaucoma
Cone Rod Dystrophy
Macular Degeneration
Image of trial facility.

Gene Therapy

for Retinitis Pigmentosa

The purpose of this study is to assess the safety and tolerability of subretinal delivery of Adeno-associated Virus Vector (AAV5 hRKp.RPGR) gene therapy in adults and children with X-linked retinitis pigmentosa.
Recruiting1 award Phase 2
Image of trial facility.

Rare Gene Study

for Retinitis Pigmentosa

This is an international, multicenter study with two components: Registry * A standardized genetic screening and a prospective, standardized, cross-sectional clinical data collection * Enrollment is open to all genes on the RD Rare Gene List Natural History Study * A prospective, standardized, longitudinal Natural History Study * Enrollment opens gene-by-gene, based on funding and within-gene Registry enrollment The study objectives are as follows. Registry Objectives 1. Genotype Characterization 2. Cross-Sectional Phenotype Characterization (within gene) 3. Establish a Link to My Retina Tracker Registry (MRTR) 4. Ancillary Exploratory Studies - Pooling of Genes Natural History Study Objectives 1. Natural History (within gene) 2. Structure-Function Relationship (within gene) 3. Risk Factors for Progression (within gene) 4. Ancillary Exploratory Studies - Pooling of Genes
Recruiting1 award N/A10 criteria
Image of trial facility.

VP-001

for Retinal Dystrophy

A Phase 1 Open-Label, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants with Confirmed PRPF31 Mutation-Associated Retinal Dystrophy
Recruiting1 award Phase 13 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Michigan, Kellogg Eye Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security